Africa Cancer Chemotherapy Market Outlook (2021-2031)
The Africa Cancer Chemotherapy Market size is expected to reach US$ 1,199.9 million by 2031 from US$ 723.2 million in 2024. The market is estimated to record a CAGR of 7.5% from 2025 to 2031.
Report Coverage
- Therapy Type: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Therapy Type
- Indication: Blood Cancer, Lung Cancer, Breast Cancer, Colorectum Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications
- End User: Hospital Pharmacies, Retail Pharmacies, Online Stores
US$ 723.2 Mn
Market size in 2024
US$ 1,199.9 Mn
Market Size by 2031
7.5%
CAGR, 2025 - 2031
2025-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Africa Cancer Chemotherapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Africa Cancer Chemotherapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Africa Cancer Chemotherapy Market Regional Analysis
6.2 Africa Cancer Chemotherapy Market Revenue 2021-2031 (US$ Million)
6.3 Africa Cancer Chemotherapy Market Forecast Analysis
7. Africa Cancer Chemotherapy Market Analysis – by Therapy Type
7.1 Alkylating Agents
- 7.1.1 Overview
- 7.1.2 Alkylating Agents: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Antimetabolites
- 7.2.1 Overview
- 7.2.2 Antimetabolites: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Anti-Tumor Antibiotics
- 7.3.1 Overview
- 7.3.2 Anti-Tumor Antibiotics: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Topoisomerase Inhibitors
- 7.4.1 Overview
- 7.4.2 Topoisomerase Inhibitors: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Mitotic Inhibitors
- 7.5.1 Overview
- 7.5.2 Mitotic Inhibitors: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Other Therapy Type
- 7.6.1 Overview
- 7.6.2 Other Therapy Type: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Africa Cancer Chemotherapy Market Analysis – by Indication
8.1 Blood Cancer
- 8.1.1 Overview
- 8.1.2 Blood Cancer: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Lung Cancer
- 8.2.1 Overview
- 8.2.2 Lung Cancer: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Breast Cancer
- 8.3.1 Overview
- 8.3.2 Breast Cancer: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Colorectum Cancer
- 8.4.1 Overview
- 8.4.2 Colorectum Cancer: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Prostate Cancer
- 8.5.1 Overview
- 8.5.2 Prostate Cancer: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Stomach Cancer
- 8.6.1 Overview
- 8.6.2 Stomach Cancer: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Cervical Cancer
- 8.7.1 Overview
- 8.7.2 Cervical Cancer: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.8 Liver and Intrahepatic Bile Duct Cancer
- 8.8.1 Overview
- 8.8.2 Liver and Intrahepatic Bile Duct Cancer: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.9 Thyroid Cancer
- 8.9.1 Overview
- 8.9.2 Thyroid Cancer: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.10 Other Indications
- 8.10.1 Overview
- 8.10.2 Other Indications: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Africa Cancer Chemotherapy Market Analysis – by End User
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Stores
- 9.3.1 Overview
- 9.3.2 Online Stores: Africa Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Africa Cancer Chemotherapy Market – Africa Analysis
10.1 Overview
10.2 Africa- 10.2.1 Africa Cancer Chemotherapy Market Breakdown, by Key Country, 2025 and 2031 (%)
- 10.2.1.1 Africa Cancer Chemotherapy Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 Egypt: Africa Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 Egypt: Africa Cancer Chemotherapy Market Breakdown, by Therapy Type
- 10.2.1.1.2 Egypt: Africa Cancer Chemotherapy Market Breakdown, by Indication
- 10.2.1.1.3 Egypt: Africa Cancer Chemotherapy Market Breakdown, by End User
- 10.2.1.2 South Africa: Africa Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 South Africa: Africa Cancer Chemotherapy Market Breakdown, by Therapy Type
- 10.2.1.2.2 South Africa: Africa Cancer Chemotherapy Market Breakdown, by Indication
- 10.2.1.2.3 South Africa: Africa Cancer Chemotherapy Market Breakdown, by End User
- 10.2.1.3 Nigeria: Africa Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Nigeria: Africa Cancer Chemotherapy Market Breakdown, by Therapy Type
- 10.2.1.3.2 Nigeria: Africa Cancer Chemotherapy Market Breakdown, by Indication
- 10.2.1.3.3 Nigeria: Africa Cancer Chemotherapy Market Breakdown, by End User
- 10.2.1.4 and Algeria: Africa Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 and Algeria: Africa Cancer Chemotherapy Market Breakdown, by Therapy Type
- 10.2.1.4.2 and Algeria: Africa Cancer Chemotherapy Market Breakdown, by Indication
- 10.2.1.4.3 and Algeria: Africa Cancer Chemotherapy Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Astellas Pharma Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Eli Lilly and Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Novartis AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Merck KGaA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Johnson & Johnson
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 AstraZeneca
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Pfizer Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Bristol Myers Squibb
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 F. Hoffmann-La Roche Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 AbbVie
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
